Source: iQoncept / Shutterstock
Apogee Therapeutics (NASDAQ:APGE) recently unveiled its performance for the final quarter of 2023.
- Remarkably, Apogee Therapeutics posted earnings per share of -32 cents, surpassing analysts’ projections of -49 cents for EPS.
- However, the company did not disclose any revenue figures for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/apge-stock-earnings-apogee-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC